EANO Youngsters

  • EANO Youngsters

Call for members for the EANO Youngsters Committee

The EANO Youngsters provides a platform for networking, interaction and collaboration between young scientists and clinicians with a special interest in Neuro-Oncology. The EANO Youngsters Track during the Scientific Meeting is only one of our successful projects. We also organize well-attended tumorboard webinars, closely collaborate with the Educational Committee in the organization of the EANO Mentorship Program, the Educational day and other educational activities, and are active on Social Media. Importantly, the EANO Youngsters committee aims to represent the diversity of EANO with a lot of different specialties involved in Neuro-Oncology as well as to represent the different scientific interest from a clinical as well as a translational and basic science viewpoint.

To further broaden the projects of the EANO Youngsters Committee, we are looking for new motivated members with new ideas for projects, initiatives and actions to improve networking, interactions and collaborations between young scientists with a special interest in Neuro-Oncology. EANO Youngsters Committee does not focus on scientific projects, but aims to increase the involvement of young members in the EANO society. The duration of the position is 2 years, with the possibility of one re-election.

If you have an idea for the EANO Youngsters Committee, you are under 35 years old and want to join the EANO Youngster Committee, please send your proposal along with a short motivation letter and CV at the latest by May 15th, 2022 to youngsters@eano.eu. Early career basic scientists (e.g. PhD candidates) are especially encouraged to apply.

Call for the EANO Youngsters Committee at a glance

- Young EANO Members (age < 35 years)

- Project idea (max. 1 page)

- Motivation letter (max. ½ page)

- CV

Send to youngsters@eano.eu at the latest by May 15th, 2022

Applications will be reviewed by the current EANO Youngster Committee and new members will be invited based on the project idea, regional/gender/professional background diversity.

 

 

Perioperative imaging in patients treated with resection of brain metastases: a survey by the EANO Youngsters committee

Neurosurgical resection is crucial in the multimodal treatment of brain metastases. However, no widely accepted guidelines for perioperative imaging for brain metastases are currently available to guide postoperative therapy. To optimize standardized management and adjuvant treatment decisions for patients with brain metastases on an international level the EANO Youngsters committee performed for the first-time an international survey via the EANO network. The aim of this study was to analyze the different perioperative imaging modalities applied at various neurooncological centers worldwide in patients with brain metastasis.

According to this survey, MRI was the preferred imaging method in the preoperative setting. In the postoperative course, imaging modalities and timing showed high variability. International guidelines for perioperative imaging with special focus on postoperative MRI to determine the extent of resection are warranted to optimize standardized management and adjuvant treatment decisions for patients with brain metastases.

Reference: Kiesel, B., Thomé, C.M., Weiss, T. et al. Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee. BMC Cancer 20, 410 (2020). doi: 10.1186/s12885-020-06897-z.

Most Popular Scientific Neuro-oncology Papers in 2019

According to the EANO Youngsters

The EANO Youngsters selected the most important scientific neuro-oncology papers of 2019. Instead of just looking at the number of citations or impact factors, we performed a survey in our EANO Youngsters Facebook group. We received a lot of input! We now have an interesting impression of which studies our followers were most interested in this year.
This year's list features important basic science papers, published in high-impact journals, and possible practice-changing clinical papers.

So, here are our top 6 paper:

  1. Suva group's single cell paper: Neftel C. et al. (2019) An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell, 178(4):835-849.e21. doi: 10.1016/j.cell.2019.06.024. https://www.ncbi.nlm.nih.gov/pubmed/31327527
  2. The Nature-trio on synaptic interactions between glioma cells and neurons: Barrier A. Dangerous liaisons as tumour cells form synapses with neurons. Nature (2019) 573, 499-501, doi: 10.1038/d41586-019-02746-7 https://www.nature.com/articles/d41586-019-02746-7
  3. Taylor group's snRNA paper: Suzuki H. et al. . Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma. Nature. (2019). doi: 10.1038/s41586-019-1650-0. https://www.ncbi.nlm.nih.gov/pubmed/31597162
  4. Exciting work from the Glioma Longitudinal Analysis (GLASS) Consortium: Barthel, F.P., Johnson, K.C., Varn, F.S. et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature (2019) doi:10.1038/s41586-019-1775-1 https://www.nature.com/articles/s41586-019-1775-1
  5. Whole brain radiotherapy with or without hippocampal avoidance in brain metastases: Tomé W. et al. RADI-11. NRG ONCOLOGY CC001: A PHASE III TRIAL OF HIPPOCAMPAL AVOIDANCE IN ADDITION TO WHOLE-BRAIN RADIOTHERAPY (WBRT) PLUS MEMANTINE TO PRESERVE NEUROCOGNITIVE FUNCTION IN PATIENTS WITH BRAIN METASTASES (BM), Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i23–i24, doi.org/10.1093/noajnl/vdz014.104 https://academic.oup.com/noa/article/1/Supplement_1/i23/5546283
  6. Lomustine-temozolomide or standard temozolomide therapy in glioblastoma: Herrlinger U. et al. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. The Lancet (2019) 393 (10172), P678-688, doi.org/10.1016/S0140-6736(18)31791-4 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31791-4/fulltext?dgcid=raven_jbs_etoc_email

Follow us on facebook

The EANO Youngsters facebook group should help to interact with other youngsters more early. Exchange experience and information, ask for advise from the community and share interesting information e.g. on trials or papers. Not yet connected? Just enter “EANO Youngsters” and join the community!